logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10864217 B1

PDFFull Text
Date of Patent:
Dec. 15, 2020

Filed:

May. 24, 2019

Use of inhibitor of apoptosis protein (iap) antagonists in hiv therapy

Applicants:

Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA (US);

Salk Institute for Biological Studies, La Jolla, CA (US);

Inventors:

Lars Pache, La Jolla, CA (US);

Sumit K. Chanda, La Jolla, CA (US);

Mitchell Dennis Vamos, La Jolla, CA (US);

Nicholas David Peter Cosford, La Jolla, CA (US);

Peter Teriete, La Jolla, CA (US);

John Marlett, La Jolla, CA (US);

Arturo Diaz, La Jolla, CA (US);

John A. T. Young, La Jolla, CA (US);

Assignees:

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, La Jolla, CA (US);

SALK INSTITUTE FOR BIOLOGICAL STUDIES, La Jolla, CA (US);

Attorney:

Wilson Sonsini Goodrich & Rosati

Primary Examiner:

Brenda L Coleman

Int. Cl.
CPC ...
A61K 31/553 (2006.01); A61P 31/18 (2006.01); C07D 487/04 (2006.01); A61K 31/554 (2006.01); A61K 45/06 (2006.01); A61K 31/167 (2006.01); A61K 31/18 (2006.01); A61K 31/20 (2006.01); A61K 31/27 (2006.01); A61K 31/4045 (2006.01); A61K 31/4406 (2006.01); A61K 31/5365 (2006.01); A61K 31/55 (2006.01); A61K 31/551 (2006.01);
U.S. Cl.
CPC ...
A61K 31/553 (2013.01); A61K 31/167 (2013.01); A61K 31/18 (2013.01); A61K 31/20 (2013.01); A61K 31/27 (2013.01); A61K 31/4045 (2013.01); A61K 31/4406 (2013.01); A61K 31/5365 (2013.01); A61K 31/55 (2013.01); A61K 31/551 (2013.01); A61K 31/554 (2013.01); A61K 45/06 (2013.01);
Abstract

Provided herein is the use of compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), alone or in combination with other therapeutic agents, in the treatment of human immunodeficiency virus (HIV).

Find Patent Forward Citations

Loading…